Supplies industrial gases like oxygen, nitrogen, argon, and hydrogen. Provides medical gases, hygiene products, and healthcare services. Now — the numbers.
This is an established company with proven profits.
No real growth (4% a year).
The gap is $11.2B. In times of high interest rates, a gap like that can squeeze a company.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
R&D Investment: Spending on future research is low.
The stock trades below its recent peak — about 13% off the top. A pullback, not a collapse.
It pays out $3.90 per share each year — regular cash for whoever holds the stock.
The share set aside for the future is small; the pace of new ideas may slow. Council score: 2/10.
Getting in and out without moving the price could prove difficult. Council score: 2/10.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the revenue breakdown.